EUVIMEDEUVIMED entdecken
Crossref

Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T‐cell therapy

Nicol Garcia-Pouton, Valentín Ortiz-Maldonado, Oliver Peyrony iD, Mariana Chumbita iD, Tommaso Francesco Aiello iD, Patricia Monzo-Gallo iD, Carlos Lopera, Pedro Puerta-Alcalde, Laura Magnano, Nuria Martinez-Cibrian, Cristina Pitart iD, Manel Juan und 5 weitere

European Journal of Haematology · 2024

DOI: 10.1111/ejh.14122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Nicol Garcia-Pouton und 16 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Bacterial Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: European Regional Development Fund, Instituto de Salud Carlos III, Ministerio de Sanidad, Consumo y Bienestar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We described the real‐life epidemiology and causes of infections on the different therapy phases in patients undergoing chimeric antigen receptor (CAR) T‐cells directed towards CD19+ or BCMA+ cells.

Methods

All consecutive patients receiving CAR T‐cell therapy at our institution were prospectively followed‐up. We performed various comparative analyses of all patients and subgroups with and without infections.

Results

Ninety‐one adults mainly received CAR T‐cell therapy for acute leukaemia (53%) and lymphoma (33%). We documented a total of 77 infections in 47 (52%) patients, 37 (48%) during the initial neutropenic phase and 40 (52%) during the non‐neutropenic phase. Infections during the neutropenic phase were mainly due to bacterial (29, 78%): catheter infections (11 [38%] cases), endogenous source (5 [17%]), and Clostridioides difficile (5 [17%]). Patients receiving corticosteroids after CAR T‐cell therapy had a higher risk of endogenous infection (100% vs. 16%; p = .006). During the non‐neutropenic phase, bacterial infections remained very frequent (24, 60%), mainly with catheter source (8, 33%). Respiratory tract infections were common (17, 43%).

Conclusions

Infections after CAR T‐cell therapy were frequent. During the neutropenic phase, it is essential to prevent nosocomial infections and balance the use of antibiotics to lower endogenous bacteraemia and Clostridial infection rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsLymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaBacterial InfectionsAdultHumansImmunotherapy, AdoptiveAntigens, CD19

Stichwörter der Autor:innen

CAR T-cellepidemiologyhaematological malignanciesinfections

Substanzen

Antigens, CD19

Autor:innen und Institutionen

  • Infectious Diseases Department, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Haematology Department, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Emergency Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Microbiology Department, Hospital Clinic, University of Barcelona, ISGLOBAL, Barcelona, Spain.
  • Immunology Department, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • CIBERINF, CIBER in Infectious Diseases, Barcelona, Spain.

ORCID-Profile: Oliver Peyrony, Mariana Chumbita, Tommaso Francesco Aiello, Patricia Monzo-Gallo, Cristina Pitart, Álex Soriano, Carolina Garcia-Vidal

Förderung

  • European Regional Development Fund
  • Instituto de Salud Carlos III
  • Ministerio de Sanidad, Consumo y Bienestar

Zitieren

APA

Garcia-Pouton, N., Ortiz-Maldonado, V., Peyrony, O., Chumbita, M., Aiello, T. F., Monzo-Gallo, P., Lopera, C., Puerta-Alcalde, P., Magnano, L., Martinez-Cibrian, N., Pitart, C., Juan, M., Delgado, J., Fernandez De Larrea, C., Soriano, Á., Urbano-Ispizua, Á., & Garcia-Vidal, C. (2024). Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T‐cell therapy. European Journal of Haematology. https://doi.org/10.1111/ejh.14122

Vancouver

Garcia-Pouton N, Ortiz-Maldonado V, Peyrony O, Chumbita M, Aiello TF, Monzo-Gallo P, et al. Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T‐cell therapy. European Journal of Haematology. 2024. doi:10.1111/ejh.14122

BibTeX
@article{GarciaPouton2024,
  author = {Garcia-Pouton, Nicol and Ortiz-Maldonado, Valentín and Peyrony, Oliver and Chumbita, Mariana and Aiello, Tommaso Francesco and Monzo-Gallo, Patricia and Lopera, Carlos and Puerta-Alcalde, Pedro and Magnano, Laura and Martinez-Cibrian, Nuria and Pitart, Cristina and Juan, Manel and Delgado, Julio and Fernandez De Larrea, Carlos and Soriano, Álex and Urbano-Ispizua, Álvaro and Garcia-Vidal, Carolina},
  title = {Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T‐cell therapy},
  journal = {European Journal of Haematology},
  year = {2024},
  doi = {10.1111/ejh.14122}
}
Kostenlos starten →